Evidence map›Paper›PMID 37529282›Full record

ArticleQRB discovery2022

Modelling peptide-protein complexes: docking, simulations and machine learning.

Arup Mondal, Liwei Chang, Alberto Perez

Abstract read
In one paragraph

Article in QRB discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Strategic Template Filtering Accelerates Fragment-Based Peptide Docking.Journal of chemical information and modeling · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Peptide-protein docking: from physics-based models to generative intelligence.Chemical communications (Cambridge, England) · 2026
    Review
  10. Proteome-wide prediction of interactions between structured domains and peptide motifs reveals functionally coherent subnetworks.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Review
  12. Peptide-based drug design using generative AI.Chemical communications (Cambridge, England) · 2026
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arup MondalDepartment of Chemistry, University of Florida, Gainesville, FL 32611, USA.ORCID https://orcid.org/0000-0002-8970-3380
Liwei ChangDepartment of Chemistry, University of Florida, Gainesville, FL 32611, USA.ORCID https://orcid.org/0000-0001-5847-0820
Alberto PerezDepartment of Chemistry, University of Florida, Gainesville, FL 32611, USA.ORCID https://orcid.org/0000-0002-5054-5338

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptides mediate up to 40% of protein interactions, their high specificity and ability to bind in places where small molecules cannot make them potential drug candidates. However, predicting peptide-protein complexes remains more challenging than protein-protein or protein-small molecule interactions, in part due to the high flexibility peptides have. In this review, we look at the advances in docking, molecular simulations and machine learning to tackle problems related to peptides such as predicting structures, binding affinities or even kinetics. We specifically focus on explaining the number of docking programmes and force fields used in molecular simulations, so a prospective user can have an educated guess as to why choose one modelling tool or another to address their scientific questions.

Indexed as

Dockingforce fieldmachine learningmolecular dynamics simulationpeptide bindingpeptide–protein interactionscoring

Identifiers

PMID37529282
PMCPMC10392694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.